LB Pharmaceuticals Inc: Form SCHEDULE 13D/A, filed Feb 10, 2026
Filed with the SEC on Feb 10, 2026 and accepted by EDGAR at Feb 10, 2026, 16:30 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-044781. Last ingested by Listed: Nov 5, 2026, 18:54 ET. Listed shows no prices and gives no investment advice.